High Incidence of Early Human Herpesvirus-6 Infection in Children Undergoing Haploidentical Manipulated Stem Cell Transplantation for Hematologic Malignancies

Ogata, 2009, Human herpesvirus 6 in hematological malignancies, J Exp Clin Hematop, 49, 57, 10.3960/jslrt.49.57 Nukui, 2015, A human herpesvirus 6A-encoded microRNA: role in viral lytic replication, J Virol, 89, 2615, 10.1128/JVI.02007-14 De Bolle L, 2005, Update on human herpesvirus 6 biology, clinical features, and therapy, Clin Microbiol Rev, 18, 217, 10.1128/CMR.18.1.217-245.2005 Miyagawa, 2018, Predominant contribution of CD4 T cells to human herpesvirus 6 (HHV-6) load in the peripheral blood of patients with drug-induced hypersensitivity syndrome and persistent HHV-6 infection, Acta Derm Venereol, 92, 146, 10.2340/00015555-2791 Hentrich, 2005, Impact of human herpes virus-6 after haematopoietic stem cell transplantation, Br J Haematol, 128, 66, 10.1111/j.1365-2141.2004.05254.x Imbert-Marcille, 2000, Human herpes virus-6 infection after autologous or allogeneic stem cell transplantation: a single center prospective longitudinal study of 92 patients, Clin Infect Dis, 31, 881, 10.1086/318142 Zerr, 2005, Clinical outcomes of human herpes virus 6 reactivation after hematopoietic stem cell transplantation, Clin Infect Dis, 40, 932, 10.1086/428060 Olson, 2014, Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double unit cord blood recipients transplanted without anti-thymocyte globulin, Biol Blood Marrow Transplant, 20, 787, 10.1016/j.bbmt.2014.02.010 Wainwright, 2001, Human herpesvirus 6 limbic encephalitis after stem cell transplantation, Ann Neurol, 50, 612, 10.1002/ana.1251 Zerr, 2006, Human herpesvirus 6 and central nervous system disease in hematopoietic stem cell transplantation, J Clin Virol, 37, S52, 10.1016/S1386-6532(06)70012-9 Seeley, 2007, Post-transplant acute limbic encephalitis: clinical feature and relationship to HHV-6, Neurology, 69, 156, 10.1212/01.wnl.0000265591.10200.d7 Provenzale, 2008, Extrahippocampal involvement in human herpesvirus 6 encephalitis depicted at MR imaging, Radiology, 249, 955, 10.1148/radiol.2492071917 Carrigan, 1991, Interstitial pneumonitis associated with human herpesvirus 6 infection after marrow transplantation, Lancet, 338, 147, 10.1016/0140-6736(91)90137-E Cone, 1993, Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation, N Engl J Med, 329, 156, 10.1056/NEJM199307153290302 Drobyski, 1993, Human herpesvirus 6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo, J Infect Dis, 167, 735, 10.1093/infdis/167.3.735 Pichereau, 2012, The complex relationship between human herpesvirus 6 and acute graft-versus-host disease, Biol Blood Marrow Transplant, 18, 141, 10.1016/j.bbmt.2011.07.018 Le Bourgeois, 2014, Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults, Exp Hematol, 42, 945, 10.1016/j.exphem.2014.07.264 De Patger PJ, 2008, Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome, Biol Blood Marrow Transplant, 14, 831, 10.1016/j.bbmt.2008.04.016 Admiraal, 2017, Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation, J Allergy Clin, 140, 1643, 10.1016/j.jaci.2016.12.992 7th European Conference on Infections in Leukemia. Available at: www.ecil-leukemia.com. Di Ianni, 2011, Tregs prevent GvHD and promote immune reconstitution in HLA-haploidentical transplantation, Blood, 117, 3921, 10.1182/blood-2010-10-311894 Martelli, 2014, HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse, Blood, 124, 638, 10.1182/blood-2014-03-564401 Vadakekolathu, 2017, T-cell manipulation strategies to prevent graft-versus-host disease in haploidentical stem cell transplantation, Biomedicines, 5, 33, 10.3390/biomedicines5020033 Triplett, 2018, Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared to CD3-targeted T-cell depletion, Transpl Infect Dis, 10.1111/tid.12823 Hymas, 2005, Use of lyophilized standards for the calibration of a newly developed real time PCR assay for human herpes type six (HHV6) variants A and B, J Virol Methods, 128, 143, 10.1016/j.jviromet.2005.05.003 Cavagna, 2013, Chromosomally integrated human herpesvirus 6 in a patient with systemic lupus erythematosus, Lupus, 22, 1087, 10.1177/0961203313498794 Ciccocioppo, 2011, Human herper virus-6 chromosomal integration misled the management of Crohn's disease, Inflamm Bowel Dis, 17, E113, 10.1002/ibd.21790 Przepiorka, 1994, Consensus conference on acute GvHD grading, Bone Marrow Transplant, 15, 825 De Pauw, 2008, Clin Infect Dis, 46, 1813, 10.1086/588660 Wood, 2017, Chromosomally integrated human herpesvirus 6: models of viral genome release from the telomere and impacts on human health, Viruses, 9:184 Hill, 2017, Outcomes of hematopoietic cell transplantation using donor or recipients with inherited chromosomally integrated HHV-6, Blood, 130, 1062, 10.1182/blood-2017-03-775759 Pantry, 2017, Latency, integration and reactivation of human herpesvirus-6, Viruses, 9, 194, 10.3390/v9070194 Tang, 2013, CD134 is a cellular receptor specific for human herpesvirus-B entry, Proc Natl Acad Sci USA, 110, 9096, 10.1073/pnas.1305187110 Liszewski, 1991, Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster, Ann Rev Immunol, 9, 431, 10.1146/annurev.iy.09.040191.002243 Greco, 2016, Human herpes virus 6 infection following haploidentical transplantation: immune recovery and outcome, Biol Blood Marrow Transplant, 22, 2250, 10.1016/j.bbmt.2016.09.018 Goldberg, 2017, Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant, Leuk Lymph, 58, 1859, 10.1080/10428194.2016.1265113 Reymen, 1995, Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6, Antiviral Res, 28, 343, 10.1016/0166-3542(95)00058-5 Shiraki, 1989, Phosphonoacetic acid inhibits replication of human herpesvirus 6, Antiviral Res, 12, 311, 10.1016/0166-3542(89)90058-2 Ogata, 2010, Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients, Bone Marrow Transplant, 45, 129, 10.1038/bmt.2009.116 Eliassen, 2017, The interplay between natural killer cells and human herpes virus 6, Viruses, 9, 367, 10.3390/v9120367 Perruccio, 2015, Differences in Aspergillus-specific immune recovery between T-cell replete and T-cell-depleted hematopoietic transplants, Eur J Haematol, 95, 551, 10.1111/ejh.12531 Marty, 2013, CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation, N Engl J Med, 369, 1227, 10.1056/NEJMoa1303688 Bonnafous, 2013, HDP-CDV as an alternative for treatment of human herpesvirus-6 infection, J Clin Virol, 522, 175, 10.1016/j.jcv.2012.11.006